Value-Based Care vs. Fee-for-Service: What Healthcare Finance and Compliance Teams Need to Know

Every healthcare organisation runs on a payment model, whether or not the finance and compliance teams built it themselves. In the US and increasingly elsewhere, that model is shifting — from paying for volume to paying for outcomes. Understanding the practical difference between fee-for-service and value-based care isn't just a policy question anymore; it shapes how finance teams forecast revenue, how compliance teams design documentation and audit processes, and how trained, credentialed staff are deployed across a growing mix of contracts.

What is fee-for-service?

Fee-for-service (FFS) is the traditional payment model: a provider delivers a service — a consultation, a procedure, a diagnostic test — and bills for it. Payment is tied to volume and activity, not to the outcome of the care delivered. More visits, more tests, and more procedures generally mean more revenue, regardless of whether the patient's health actually improved.

FFS is administratively familiar and relatively simple to bill against, which is part of why it has remained the dominant model for decades. But it creates a structural incentive problem: it rewards doing more, not doing better, and it puts no direct financial weight on care coordination, prevention, or avoiding unnecessary utilisation.

What is value-based care?

The Centers for Medicare & Medicaid Services (CMS) defines value-based care as health care "designed to focus on quality of care, provider performance and the patient experience," rather than on the volume of services delivered. Instead of billing per service, providers are paid — in whole or in part — based on patient outcomes, care quality, and cost efficiency. Common value-based arrangements include:

• Accountable Care Organizations (ACOs) — groups of doctors, hospitals, and other providers who coordinate care for a defined patient population and share in the savings (and sometimes the losses) against a cost benchmark.
• Bundled payments — a single payment covers all the care associated with an episode (a hip replacement, for example), pushing providers to coordinate rather than bill separately at each step.
• Pay-for-performance / quality-based contracts — a portion of payment is tied directly to measured quality indicators, such as readmission rates or preventive screening completion.

Fee-for-service vs. value-based care: the core differences

Why this matters for finance and compliance teams specifically

The shift toward value-based arrangements changes what "getting it right" means for both functions. For finance, revenue under a shared-savings or bundled-payment contract is no longer a predictable function of visit volume — it depends on how the organisation performs against a benchmark that may not be finalised until well after the care was delivered, which makes forecasting and cash-flow planning materially harder. Understanding how that revenue actually flows is easier with a solid grounding in revenue cycle management, since value-based contracts add layers — risk adjustment, quality-measure reconciliation, shared-savings settlement — on top of the traditional claim-to-payment cycle.

For compliance, the stakes move beyond "was this service billed correctly" to "was this patient's risk accurately and honestly documented, and can the quality metrics we reported be substantiated in an audit." Risk-adjustment and quality-reporting integrity have become a genuine enforcement focus, and organisations moving into value-based contracts for the first time often underestimate how much new documentation discipline that requires from clinical and coding staff alike. The habits that support strong survey and audit readiness in other regulatory contexts — accurate, timely, defensible documentation — apply directly here.

Where the shift actually stands

The move toward value-based care is well underway but far from complete. As of January 2026, CMS estimates that 14.3 million Medicare beneficiaries are receiving care coordinated through an Accountable Care Organization, up from 13.7 million a year earlier. The Medicare Shared Savings Program (MSSP) — the largest ACO programme — grew to 511 participating ACOs in 2026, up from 476, and is projected to serve 12.6 million traditional Medicare beneficiaries this year, a 12.3% increase and the largest number the programme has ever served. In performance year 2024, MSSP ACOs earned $4.1 billion in shared savings and reduced Medicare spending by $2.5 billion relative to their benchmarks. CMS's Innovation Center has stated an ongoing strategic priority of moving more Medicare and Medicaid beneficiaries into accountable care arrangements that carry genuine downside financial risk, rather than upside-only participation — a signal that the direction of travel, even if the pace and specific targets shift with policy, is toward more risk-bearing value-based contracts, not fewer.

What finance and compliance teams should be doing now

• Build risk-adjustment literacy across coding and clinical documentation staff. Accurate diagnosis coding under value-based contracts directly affects both revenue and compliance exposure — this is a training gap in most organisations that have primarily operated under FFS.
• Separate FFS and value-based revenue in forecasting. Treating shared-savings or bundled-payment revenue with the same forecasting logic as FFS billing tends to produce unreliable projections.
• Audit quality-measure reporting the way you'd audit a billing claim. If a quality metric drives payment, it needs the same documentation trail and internal review as a billed service.
• Train staff on both models, not just the one you're moving away from. Most organisations run a hybrid of FFS and value-based contracts for years during the transition — staff need working fluency in both, not a hard cutover.

FAQ

Does value-based care replace fee-for-service entirely?
Not in most organisations, and not yet at a system level. Many providers operate a blend — FFS for some payers or service lines, value-based arrangements for others — often for years at a time.

Is value-based care riskier for providers financially?
It can be, particularly in downside-risk arrangements where providers repay the payer if costs exceed the benchmark. That's exactly why documentation accuracy and cost management discipline matter more, not less, under value-based contracts.

What's the biggest compliance risk in the shift to value-based care?
Risk-adjustment and quality-measure reporting that can't be substantiated on audit — the analogue, in a value-based world, of upcoding or unbundling under FFS.

The organisations that handle this transition well aren't necessarily the ones moving fastest into value-based contracts — they're the ones whose finance and compliance teams understand both models well enough to operate confidently in the mixed reality most providers actually face.